Andrew S. Davis - 01 Sep 2021 Form 4 Insider Report for Silk Road Medical Inc

Role: Chief Commercial Officer
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 01 Sep 2021
Net transactions value: -$356,776
Form type: 4
Filing time: 03 Sep 2021, 17:49:00 UTC
Previous filing: 03 Aug 2021
Next filing: 05 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Options Exercise	$3,670	+776	+1.1%	$4.73	71,188	01 Sep 2021	Direct	F1
transaction	SILK	Common Stock	Sale	$46,348	-776	-1.1%	$59.73	70,412	01 Sep 2021	Direct	F1, F2
transaction	SILK	Common Stock	Options Exercise	$25,324	+5,354	+7.6%	$4.73	75,766	01 Sep 2021	Direct	F1
transaction	SILK	Common Stock	Sale	$319,776	-5,354	-7.1%	$59.73	70,412	01 Sep 2021	Direct	F1, F2
transaction	SILK	Common Stock	Options Exercise	$1,185	+194	+0.28%	$6.11	70,606	01 Sep 2021	Direct	F1
transaction	SILK	Common Stock	Sale	$11,587	-194	-0.27%	$59.73	70,412	01 Sep 2021	Direct	F1, F2
transaction	SILK	Common Stock	Sale	$9,246	-157	-0.22%	$58.89	70,255	01 Sep 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Options Exercise	$0	-776	-1.1%	$0.000000	66,969	01 Sep 2021	Common Stock	776	$4.73	Direct	F1, F4
transaction	SILK	Option (right to buy)	Options Exercise	$0	-5,354	-15%	$0.000000	29,956	01 Sep 2021	Common Stock	5,354	$4.73	Direct	F1, F4
transaction	SILK	Option (right to buy)	Options Exercise	$0	-194	-6.5%	$0.000000	2,768	01 Sep 2021	Common Stock	194	$6.11	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F2	This transaction was executed in multiple trades at price ranging from $59.06 to $60.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F4	All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F5	One forty-eighth of the shares subject to the option shall vest on August 1, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.